Voyager Therapeutics (VYGR) FCF Margin Growth (1y) (2016 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 682.00 |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 1.20 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 5,823.00 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -189.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 26,580.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -1.30 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 226,818.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 1,141.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1,854.00 |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -15,293.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,293.00 |
| Mar 31, 2026 | -69,276.00 |
| Dec 31, 2025 | 3,248.00 |
| Sep 30, 2025 | -11,864.00 |
| Jun 30, 2025 | -55,093.00 |
| Mar 31, 2025 | -88,327.00 |
| Dec 31, 2024 | -20,668.00 |
| Sep 30, 2024 | 35,859.00 |
| Jun 30, 2024 | -6,822.00 |
| Mar 31, 2024 | 20,838.00 |
| Dec 31, 2023 | -87,735.00 |
| Sep 30, 2023 | -43,307.00 |
| Jun 30, 2023 | 270,223.00 |
| Mar 31, 2023 | -511,549.00 |
| Dec 31, 2022 | 81,149.00 |
| Sep 30, 2022 | 140,178.00 |
| Jun 30, 2022 | -105,317.00 |
| Mar 31, 2022 | 553,058.00 |
| Dec 31, 2021 | 42,923.00 |
| Sep 30, 2021 | -141,654.00 |